COVID-19. Post COVID-19 condition, unspecified
Conditions
Interventions
Intervention 1: Intervention group: At the time of visit, the PG of the patients is measured and the demographic information of the patients including age, gender, height, weight, education level, his
Sponsors
National Research Institute of Tuberculosis and Lung Diseases
Eligibility
Sex/Gender
All
Age
15 Years to No maximum
Inclusion criteria
Inclusion criteria: PCR positive for SARS-COV-2 Hyperglycemia Age above 15 years Access to mobile phones or other means of communication Access to glucometer
Exclusion criteria
Exclusion criteria: Pregnancy Impaired level of consciousness Alone patient No blood tests The patient's unwillingness to cooperate
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Fasting plasma glucose: Plasma glucose level after 8 hours of fasting. Timepoint: Fasting plasma glucose measurements will be performed at the beginning of the study and then every month for up to 3 months. Method of measurement: Plasma glucose was measured after an 8-hour fast in the hospital's central laboratory on the same day of sample collection using an autoanalyzer using a glucose kit (Pars Azmoun, Iran) via enzymatic colorimetry with the glucose oxidase method. The intra- and interassay coefficient of variation for glucose measurement was 2.2%.;Glycated haemoglobin (HbA1c): The amount of glycosylated hemoglobin in the blood, as a percentage, measured by chromatography after 8 hours of fasting. Timepoint: Serum glycated hemoglobin levels will be measured at baseline and third month. Method of measurement: Glycated hemoglobin was measured by chromatography (Audicome company, China).;Postprandial glucose: Glucose levels are measured two hours after eating the first bite of food. Timepoint: It will be measured three times a day at the beginning of the study and three times a week for 3 months. Method of measurement: Accu-Chek Performa gluco-meter (Roche company, Germany) was used to measure patients' glucose level at home. | — |
Secondary
| Measure | Time frame |
|---|---|
| Diabetes mellitus control (yes/no) Diabetes mellitus control: According to American Diabetes Association Guideline , the amount of PG, (in all measurements) and Glycated Hb should be in the following amounts: Diabetes with strict control: Glycated Hb less than 6.5 percent, Fasting plasma glucose equal to 70-130 milligrams per deciliter, Post prandial glucose less than 140 milligrams per deciliter. Diabetes with relative control: Glycated Hb less than 7 percent, Fasting plasma glucose equal to 70-130 milligrams per deciliter, Post prandial glucose less than 180 milligrams per deciliter. Uncontrolled diabetes: Glycated Hb equal or more than 7 percent, Fasting plasma glucose equal or more than 130 milligrams per deciliter, Post prandial glucose equal or more than 180 milligrams per deciliter. Timepoint: This outcome will be assessing at baseline and third month. Method of measurement: It will be performed by examining fasting plasma glucose levels, 2 hours postprandial glucose and glycosylated hemoglobin levels according to the American Diabetes Association guidelines (Standard Diabetes Care Guidelines 2026). | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactMaryam Vasheghani
National Research Institute of Tuberculosis and Lung Diseases (NRITLD)
Outcome results
None listed